The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Research Report 2024

Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1769143

No of Pages : 102

Ask Your Query

Synopsis
Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids

Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market is projected to reach US$ 1812.3 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-steroidal Anti-inflammatory Drugs for Ophthalmology market research.

Key manufacturers engaged in the Non-steroidal Anti-inflammatory Drugs for Ophthalmology industry include AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer and Sun Pharmaceutical Industries, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Non-steroidal Anti-inflammatory Drugs for Ophthalmology were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-steroidal Anti-inflammatory Drugs for Ophthalmology market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • AbbVie
  • Bausch Health
  • Bayer
  • Dossa Pharmaceuticals
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
  • Senju Pharmaceutical
  • Sichuan Heyi Pharmaceutical
  • Shandong Haishan Pharmaceutical
  • Guangdong Zhongsheng Pharmaceutical
  • Hangzhou Minsheng Pharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Pranoprofen Eye Drops
  • Diclofenac Sodium Eye Drops
  • Bromfenac Sodium Eye Drops
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Non-steroidal Anti-inflammatory Drugs for Ophthalmology report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs for Ophthalmology
1.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Segment by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Value Comparison by Type (2023-2029)
1.2.2 Pranoprofen Eye Drops
1.2.3 Diclofenac Sodium Eye Drops
1.2.4 Bromfenac Sodium Eye Drops
1.2.5 Other
1.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Segment by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size Estimates and Forecasts
1.4.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue 2018-2029
1.4.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales 2018-2029
1.4.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Competition by Manufacturers
2.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Average Price by Manufacturers (2018-2023)
2.4 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs for Ophthalmology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-steroidal Anti-inflammatory Drugs for Ophthalmology, Product Type & Application
2.7 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Competitive Situation and Trends
2.7.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-steroidal Anti-inflammatory Drugs for Ophthalmology Players Market Share by Revenue
2.7.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Retrospective Market Scenario by Region
3.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Region: 2018-2029
3.2.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Region: 2018-2023
3.2.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Region: 2024-2029
3.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Region: 2018-2029
3.3.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Region: 2018-2023
3.3.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Region: 2024-2029
3.4 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Facts & Figures by Country
3.4.1 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Country (2018-2029)
3.4.3 North America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Facts & Figures by Country
3.5.1 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Country (2018-2029)
3.5.3 Europe Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Facts & Figures by Country
3.6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Facts & Figures by Country
3.7.1 Latin America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Country (2018-2029)
3.7.3 Latin America Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Type (2018-2029)
4.1.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Type (2018-2023)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Type (2024-2029)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Market Share by Type (2018-2029)
4.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Type (2018-2029)
4.2.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Type (2018-2023)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Type (2024-2029)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue Market Share by Type (2018-2029)
4.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Application (2018-2029)
5.1.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Application (2018-2023)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales by Application (2024-2029)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Market Share by Application (2018-2029)
5.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Application (2018-2029)
5.2.1 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Application (2018-2023)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue by Application (2024-2029)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Revenue Market Share by Application (2018-2029)
5.3 Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Corporation Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bausch Health Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Dossa Pharmaceuticals
6.4.1 Dossa Pharmaceuticals Corporation Information
6.4.2 Dossa Pharmaceuticals Description and Business Overview
6.4.3 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dossa Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.4.5 Dossa Pharmaceuticals Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Janssen Pharmaceuticals
6.6.1 Janssen Pharmaceuticals Corporation Information
6.6.2 Janssen Pharmaceuticals Description and Business Overview
6.6.3 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Janssen Pharmaceuticals Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.6.5 Janssen Pharmaceuticals Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharmaceutical Industries Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Senju Pharmaceutical
6.10.1 Senju Pharmaceutical Corporation Information
6.10.2 Senju Pharmaceutical Description and Business Overview
6.10.3 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Senju Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.10.5 Senju Pharmaceutical Recent Developments/Updates
6.11 Sichuan Heyi Pharmaceutical
6.11.1 Sichuan Heyi Pharmaceutical Corporation Information
6.11.2 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Description and Business Overview
6.11.3 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Heyi Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.11.5 Sichuan Heyi Pharmaceutical Recent Developments/Updates
6.12 Shandong Haishan Pharmaceutical
6.12.1 Shandong Haishan Pharmaceutical Corporation Information
6.12.2 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Description and Business Overview
6.12.3 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shandong Haishan Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.12.5 Shandong Haishan Pharmaceutical Recent Developments/Updates
6.13 Guangdong Zhongsheng Pharmaceutical
6.13.1 Guangdong Zhongsheng Pharmaceutical Corporation Information
6.13.2 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Description and Business Overview
6.13.3 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Guangdong Zhongsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.13.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
6.14 Hangzhou Minsheng Pharmaceutical
6.14.1 Hangzhou Minsheng Pharmaceutical Corporation Information
6.14.2 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Description and Business Overview
6.14.3 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hangzhou Minsheng Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.14.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Description and Business Overview
6.15.3 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cisen Pharmaceutical Non-steroidal Anti-inflammatory Drugs for Ophthalmology Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industry Chain Analysis
7.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Production Mode & Process
7.4 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales and Marketing
7.4.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Sales Channels
7.4.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Distributors
7.5 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Customers
8 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Dynamics
8.1 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industry Trends
8.2 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Drivers
8.3 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Challenges
8.4 Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock